Screenin3D microfluidic technology is a game-changing approach for pre-clinical drug and therapy testing. At the Festival of Biologics in Basel, Dr Zagnoni presented a talk on our bespoke Onco-Chip^3D technology used for the screening of combination immunotherapies with CAR-Ts and their off-target cytotoxicity.

ScreenIn3D has been awarded the prestigious ELRIG Prize for Innovation in Drug Discovery at their flagship conference Drug Discovery 2019 which recently took place in Liverpool, UK.

(more…)

ScreenIn3D has received a share of the £1 million plus prize pot and will receive ongoing support from partners of Scottish Edge – a respected regional business support agency.

(more…)